Improvements in mortality trends for patients with multiple myeloma have been demonstrated in clinical trial and tertiary care setting in recent years. However, the generalizability of these results to community settings has not been studied as extensively.
Nandakumar et al. compared data from patients seen at Mayo Clinic in Rochester, Minnesota, to those in the Surveillance, Epidemiology, and End Results Program (SEER) from January 2004 to December 2018 to further elucidate outcomes data in less-studied populations.
Although survival outcomes continued to improve in both groups of patients, this trend was more pronounced in Mayo patients. Younger patients and those with favorable disease characteristics had the most pronounced improvements in mortality.